Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Sponsor
Northwestern University (Other)
Overall Status
Unknown status
CT.gov ID
NCT00005095
Collaborator
National Cancer Institute (NCI) (NIH)
6,000
1

Study Details

Study Description

Brief Summary

RATIONALE: To improve strategies for detection and prevention of early-stage disease.

PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.

Condition or Disease Intervention/Treatment Phase
  • Other: laboratory biomarker analysis
  • Other: screening questionnaire administration
  • Procedure: study of high risk factors

Detailed Description

OBJECTIVES:
  • To identify and develop highly sensitive and specific tumor markers for the detection and management of ovarian cancer and other gynecological malignancies.

  • To identify new prevention approaches and therapies.

  • To identify measures to improve the quality of life for women at increased risk for developing the disease and for women diagnosed with ovarian cancer.

OUTLINE: Subjects undergo periodic specimen and data collection for research studies, including molecular, biochemical, functional, and genetic marker studies. Participants may have samples of blood, tissue, or body fluids (such as ascites, pleural fluid or urine), or any combination of the aforementioned samples obtained to develop tumor markers to detect early stage or recurrent ovarian cancer.

The results from the biomarker research studies will not be reported to the patient or the physician. In the future, if any of the experimental tumor markers are found to be effective in detecting early stage ovarian cancer, and the patient's result is abnormal, the patient and physician will be notified.

Subjects may be asked to complete a combination of questionnaires designed to evaluate psychological functioning among women enrolled in a comprehensive ovarian cancer early detection program who are at increased risk for developing disease as compared to women currently diagnosed with ovarian cancer.

Study Design

Study Type:
Observational
Anticipated Enrollment :
6000 participants
Time Perspective:
Prospective
Official Title:
Northwestern Ovarian Cancer Early Detection & Prevention Program: A Specimen and Data Study
Study Start Date :
Mar 1, 2000
Anticipated Primary Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
High Risk for Ovarian Cancer

Women who are at increased risk of ovarian cancer based on family or personal medical history who are participating in the Northwestern Ovarian Cancer Early Detection and Prevention Program clinic.

Other: laboratory biomarker analysis
Subject's blood collected at their follow-up blood draw will be assessed for biomarkers that could lead to a panel for detecting early stage ovarian cancer.

Other: screening questionnaire administration
Questionnaires designed to assess quality of life for women at increased risk of ovarian cancer will be administered to the subjects. Clinical data will also be collected.

Procedure: study of high risk factors
Subjects will be assessed for high risk factors.

Outcome Measures

Primary Outcome Measures

  1. Identification and development of highly sensitive and specific tumor markers for the detection and management of ovarian cancer and other gynecological malignancies [Outcomes will be assessed at the completion of the study.]

Secondary Outcome Measures

  1. Identification of new prevention approaches and therapies [Outcomes will be assessed at the completion of the study.]

  2. Identification of measures to improve the quality of life for women at increased risk for developing the disease and for women diagnosed with ovarian cancer [Outcomes will be assessed at the completion of the study.]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
DISEASE CHARACTERISTICS:
  • Meets one of the following criteria:

  • Considered to be at increased risk for developing ovarian cancer, as defined by one of the following:

  • Has at least one first-degree relative (mother, sister, or daughter) with ovarian, primary peritoneal, or fallopian tube cancer

  • Has at least two first or second degree relatives diagnosed before age 50 with either ovarian, primary peritoneal, fallopian tube, and/or pancreatic cancer who have tested positive for hereditary cancer syndrome that includes an increased risk of gynecologic cancer (e.g., BRCA1/2 or Lynch Syndrome)or have increased risk as deemed by a certified genetic counselor

  • A personal or family history of a hereditary cancer syndrome that includes an increased risk of gynecologic cancer

  • Increased risk as deemed by a certified genetic counselor

  • Undergoing surgery for a gynecologic condition, including any of the following:

  • Diagnosis of a reproductive cancer

  • Benign gynecological condition (e.g., uterine leiomyomata, endometriosis, pelvic inflammatory disease, or follicular or corpus luteum ovarian cysts)

  • Highly suspicious adnexal mass

  • Risk-reducing prophylactic oophorectomy

PATIENT CHARACTERISTICS:

Age

  • Between the ages of 18 and 80

Contacts and Locations

Locations

Site City State Country Postal Code
1 Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago Illinois United States 60611-3013

Sponsors and Collaborators

  • Northwestern University
  • National Cancer Institute (NCI)

Investigators

  • Study Chair: Lee P. Shulman, MD, Robert H. Lurie Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lee Shulman, Chief, Division of Clinical Genetics, Northwestern University
ClinicalTrials.gov Identifier:
NCT00005095
Other Study ID Numbers:
  • NU 99G8
  • P30CA060553
  • NU-99G8
  • NCI-G00-1753
First Posted:
Jan 27, 2003
Last Update Posted:
Sep 30, 2016
Last Verified:
Sep 1, 2016

Study Results

No Results Posted as of Sep 30, 2016